Your browser doesn't support javascript.
loading
Diagnostic yield and miss rate of EndoRings in an organized colorectal cancer screening program: the SMART (Study Methodology for ADR-Related Technology) trial.
Hassan, Cesare; Senore, Carlo; Manes, Gianpiero; Fuccio, Lorenzo; Iacopini, Federico; Ricciardiello, Luigi; Anderloni, Andrea; Frazzoni, Leonardo; Ballanti, Riccardo; de Nucci, Germana; Colussi, Dora; Redaelli, Davide; Lorenzetti, Roberto; Devani, Massimo; Arena, Ilaria; Grossi, Cristina; Andrei, Fabio; Balestrazzi, Eleonora; Sharma, Prateek; Rex, Douglas K; Repici, Alessandro.
Afiliação
  • Hassan C; Endoscopy Unit, Ospedale Nuovo Regina Margherita, Rome, Italy.
  • Senore C; AOU Città della Salute e della Scienza, CPO Piemonte, Turin, Italy.
  • Manes G; Endoscopy Unit, ASST-Rhodense, Rho, Milan, Italy.
  • Fuccio L; Department of Medical and Surgical Sciences, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Iacopini F; Gastroenterology Endoscopy Unit, Ospedale S. Giuseppe, Albano Laziale, Rome, Italy.
  • Ricciardiello L; Department of Medical and Surgical Sciences, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Anderloni A; Digestive Endoscopy Unit, Humanitas Unversity, Milan, Italy.
  • Frazzoni L; Department of Medical and Surgical Sciences, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Ballanti R; Endoscopy Unit, Ospedale Santo Spirito, Rome, Italy.
  • de Nucci G; Endoscopy Unit, ASST-Rhodense, Garbagnate Milanese, Milan, Italy.
  • Colussi D; Department of Medical and Surgical Sciences, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Redaelli D; Endoscopy Unit, ASST-Rhodense, Garbagnate Milanese, Milan, Italy.
  • Lorenzetti R; Endoscopy Unit, Ospedale Santo Spirito, Rome, Italy.
  • Devani M; Endoscopy Unit, ASST-Rhodense, Rho, Milan, Italy.
  • Arena I; Endoscopy Unit, ASST-Rhodense, Rho, Milan, Italy.
  • Grossi C; Gastroenterology Endoscopy Unit, Ospedale S. Giuseppe, Albano Laziale, Rome, Italy.
  • Andrei F; Gastroenterology Endoscopy Unit, Ospedale S. Giuseppe, Albano Laziale, Rome, Italy.
  • Balestrazzi E; Department of Medical and Surgical Sciences, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Sharma P; Division of Gastroenterology & Hepatology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Missouri, USA.
  • Rex DK; Division of Gastroenterology/Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Repici A; Digestive Endoscopy Unit, Humanitas Unversity, Milan, Italy.
Gastrointest Endosc ; 89(3): 583-590.e1, 2019 03.
Article em En | MEDLINE | ID: mdl-30365984
ABSTRACT
BACKGROUND AND

AIMS:

The EndoRings add-on has been claimed to improve adenoma detection at colonoscopy, but available data are inconsistent. When testing a new technology, parallel and crossover methodologies measure different outcomes, leaving uncertainty about their correspondence. The aims of this study were to compare the diagnostic yield and miss rate of the EndoRings for colorectal neoplasia.

METHODS:

Consecutive patients undergoing colonoscopy after a positive fecal immunochemical test (FIT) within an organized screening program in 7 Italian centers were randomized between a parallel (EndoRings or standard) or a crossover (EndoRings/standard or standard/EndoRings) methodology. Outcomes measures were the adenoma detection rate (ADR) and advanced adenoma detection rate (AADR) in the parallel arms and the miss rate of adenomas in the crossover arms.

RESULTS:

Of 958 eligible patients, 927 (317 EndoRings; 317 standard; 142 EndoRings/standard; 151 standard/Endo-Rings) were included in the final analysis. In the parallel arms (mean ADR, 51.3%; mean AADR, 25.4%), no difference between standard and EndoRings was found for both ADR (relative risk [RR], 1.10; 95% confidence interval [CI], 0.95-1.28) and AADR (RR, 1.16; 95% CI, 0.88-1.51), as well as for the mean number of adenomas and advanced adenomas per patient (EndoRings, 1.9 ± 1.3 and 1.0 ± 1.2; standard, 2.1 ± 1.5 and 1.0 ± 1.2; P = not significant for both comparisons). In the crossover arms, no difference in the miss rate for adenomas between EndoRings and standard was found at per polyp (RR, 1.43; 95% CI, 0.97-2.10) or per-patient analysis (24% vs 26%; P = .76).

CONCLUSIONS:

No statistically significant difference in diagnostic yield and miss rate between EndoRings and standard colonoscopy was detected in patients with a positive FIT result. A clinically relevant correspondence between miss and detection rates was shown, supporting a cause-effect relationship. (ISRCTN registry ISRCTN10357435.).
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenoma / Colonoscopia / Erros de Diagnóstico Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Gastrointest Endosc Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenoma / Colonoscopia / Erros de Diagnóstico Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Gastrointest Endosc Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália